Related Experiment Video
Updated: Aug 22, 2025

Detecting Anastasis In Vivo by CaspaseTracker Biosensor
Published on: February 1, 2018
Cancer survivors and adverse work outcomes: associated factors and supportive interventions
Angela G E M de Boer1,2,3, Astrid de Wind1,2, Pieter Coenen2,4,5
1Public and Occupational Health, Amsterdam UMC Location University of Amsterdam, Meibergdreef 9, Amsterdam, the Netherlands.
Introduction:
The number of cancer survivors in a working age is rising. An awareness of factors associated with adverse work outcomes, and of supportive interventions, is needed.
Sources Of Data:
A narrative review of research obtained via several databases, including Medline and PsycINFO, was conducted.
Areas Of Agreement:
A range of factors is associated with adverse work outcomes such as prolonged sick leave, delayed return to work, disability pension and unemployment in cancer survivors. They include the cancer type and treatment, fatigue, cognitive functioning, work factors and elements of health care systems. Effective supportive interventions encompass physical and multicomponent interventions.
Areas Of Controversy:
The role of behaviour determinants and legislative and insurance systems is unclear. It is furthermore uncertain what the optimal timing of delivering supportive interventions is.
Growing Points:
Further focus on vulnerable groups, including specific cancer types and those with lower income, lower educational level and in precarious employment, is needed.
Areas Timely For Developing Research:
Recent developments are tailored and timely interventions.
More Related Videos
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
13:37A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies
Published on: March 12, 2014
Related Concept Videos
Cancer Survival Analysis
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Psychoneuroimmunology: Diabetes and Cancer
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy